T1	p 105 117	and Autism .
T2	p 136 204	hyperactivity disorder ( ADHD ) and autism spectrum disorder ( ASD )
T3	p 531 532	2
T4	p 610 640	. Age-matched boys with ADHD (
T5	p 648 653	ASD (
T6	p 676 678	21
T7	p 989 999	under each
T8	p 1115 1140	, ASD boys underactivated
T9	p 1199 1214	and ADHD boys .
T10	p 1345 1362	ASD boys relative
T11	p 1399 1408	ADHD boys
T12	p 1558 1561	and
T13	i 24 34	Fluoxetine
T14	i 327 366	serotonin reuptake inhibitors ( SSRIs )
T15	i 711 746	magnetic resonance imaging ( fMRI )
T16	i 786 801	scanned twice ,
T17	i 832 853	Fluoxetine or placebo
T18	i 874 892	placebo-controlled
T19	i 1077 1081	fMRI
T20	i 1107 1114	placebo
T21	i 1173 1174	)
T22	i 1281 1293	Fluoxetine ,
T23	i 1421 1428	placebo
T24	i 1491 1501	Fluoxetine
T25	i 1594 1616	suggesting dissociated
T26	o 45 73	Prefrontal Cortex Activation
T27	o 116 158	. Attention deficit hyperactivity disorder
T28	o 166 167	)
T29	o 211 239	brain function abnormalities
T30	o 390 422	flexibility and improve behavior
T31	o 485 502	disorder-specific
T32	o 1159 1165	cortex
T33	o 1242 1272	decreased precuneus activation
T34	o 1294 1309	mPFC activation
T35	o 1314 1326	up-regulated
T36	o 1469 1480	performance
T37	o 1535 1550	mPFC activation
T38	o 1592 1593	,
T39	o 1605 1637	dissociated underlying serotonin